SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-585588
Filing Date
2016-05-10
Accepted
2016-05-10 16:12:09
Documents
59
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d154213d10q.htm 10-Q 387409
2 EX-10.1 d154213dex101.htm EX-10.1 112632
3 EX-31.1 d154213dex311.htm EX-31.1 9116
4 EX-31.2 d154213dex312.htm EX-31.2 9102
5 EX-32.1 d154213dex321.htm EX-32.1 4320
12 GRAPHIC g154213ignyta_snap.jpg GRAPHIC 4689
  Complete submission text file 0001193125-16-585588.txt   3284184

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rxdx-20160331.xml EX-101.INS 549994
7 XBRL TAXONOMY EXTENSION SCHEMA rxdx-20160331.xsd EX-101.SCH 36261
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rxdx-20160331_cal.xml EX-101.CAL 54937
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rxdx-20160331_def.xml EX-101.DEF 132890
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxdx-20160331_lab.xml EX-101.LAB 350306
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxdx-20160331_pre.xml EX-101.PRE 248073
Mailing Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121
Business Address 11095 FLINTKOTE AVE. SUITE D SAN DIEGO CA 92121 (858) 255-5959
Ignyta, Inc. (Filer) CIK: 0001557421 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36344 | Film No.: 161635900
SIC: 2834 Pharmaceutical Preparations